its clear that negative revaluations really hammer the final NPAT and that any modest downward revaluation can entirely wipe out annual profit.
They have $28M cash in the bank. How do you guys think the revaluations will play out this year? Are prices and settlements still falling?
Do you think the dividend is at risk?
- Forums
- ASX - By Stock
- Vote of confidence
FRI
finbar group limited
Add to My Watchlist
3.57%
!
72.5¢

its clear that negative revaluations really hammer the final...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
72.5¢ |
Change
0.025(3.57%) |
Mkt cap ! $197.2M |
Open | High | Low | Value | Volume |
72.0¢ | 72.5¢ | 71.0¢ | $93.88K | 130.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 72.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
75.5¢ | 4777 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 0.725 |
1 | 11735 | 0.710 |
1 | 14285 | 0.700 |
1 | 719 | 0.695 |
4 | 27638 | 0.690 |
Price($) | Vol. | No. |
---|---|---|
0.755 | 4777 | 1 |
0.760 | 13159 | 1 |
0.780 | 9750 | 3 |
0.790 | 29481 | 1 |
0.805 | 4811 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
FRI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online